Regulus Therapeutics Announces Timing for Second Quarter 2021 Financial Results Webcast and Conference Call
SAN DIEGO, Aug, 3, 2021 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced that it will…
